CNP · NYSE · CIK 0001130310
CenterPoint Energy, Inc.
CenterPoint Energy, Inc. holds 3 disclosed positions, 3 of them carrying a sourced value.
CenterPoint Energy, Inc. - Profile
- Sector
- UtilitiesGICS
- Industry
- Electric ServicesSIC 4911
- Listed on
- NYSE
- Employees
- 8,827stated 2023
- Incorporated in
- Texas
- Financial year ends
- 31 December
Source
Address, industry classification, listing and incorporation come from CenterPoint Energy, Inc.'s own SEC filer record, so the industry is the SEC's dry classification rather than a marketing label. The website comes from Wikidata. The headcount is the figure the Wikipedia article states for 2023, not a figure this site has verified against a filing. The description is the opening paragraph of its Wikipedia article, used under CC BY-SA 4.0.
Share price
CNP
Description
CenterPoint Energy, Inc. is an American utility company based in Houston, Texas, that provides electric and natural gas utility to customers in several markets in the American states of Indiana, Ohio, Minnesota, and Texas. Part of the Fortune 500, the company was formerly known as Reliant Energy, NorAm Energy, Houston Industries, and HL&P. The company is headquartered in the CenterPoint Energy Tower at 1111 Louisiana Street in Downtown Houston.
Equity stakes CenterPoint Energy, Inc. holds in other companies.
modelled, reported or pending
Select a row or a slice for its provenance: the filing it came from, when it was measured, and the arithmetic behind it if it was modelled.
The full register, from 13F filings
The Register tab above is hand research: a dozen holders, each traced to the filing it came from. This asks the same question of the whole market for the quarter ended 31-mar-2026, where 803 managers reported a position. Broad where the research is deep, and shallow in the ways a 13F always is.
803 managers reported a position, together holding 661.2m shares, or 101.1% of the company. The 40 largest are listed. Percentages are of the 654.2m shares outstanding at 15 Apr 2026, the count in force when this quarter was measured rather than the count today.
This adds up to more than the whole company, and that is what the filings say. A 13F total can exceed 100% because the same share can be reported twice: when a holder lends stock, the borrower sells it to someone else, and both the lender's manager and the new buyer's manager report it. The gap tracks how heavily a stock is shorted. It is a property of 13F rather than a fault in this data, so it is shown as filed, and it cannot be used as evidence that a particular holder's stake is large.
Built from 13F filings, which report US listed, long, US custodied positions only. A register from this source is a floor rather than a level: a holder's true position can be far larger, as BlackRock's ASML stake shows at 1.28m shares in a 13F against 26.3m in its 13G/A. Holdings held through derivatives, outside US custody, or below a manager's reporting obligation do not appear. Where a holder is marked as a family, its total sums several separate filing entities and describes something no single filing describes; the constituent entities and their share counts are listed so the total can be checked. That roll-up can legitimately exceed the family's own Schedule 13G, because a 13G is filed by one legal entity: Vanguard reports Alphabet through ten advisory entities, and The Vanguard Group Inc itself reported zero after its January 2026 disaggregation.
What a reader needs to know to read these numbers
- Today is 19 August 2026; Q2 2026 (period 2026-06-30) 13F-HR filings, filed by mid-August 2026, were used throughout the register.
- shares_outstanding (658,720,288) is taken from the cover page of the 30 Jun 2026 10-Q (filed 28 Jul 2026), as of 22 Jul 2026. The balance sheet in the same 10-Q shows 658,700,905 shares outstanding as of 30 Jun 2026, essentially the same figure measured 3 weeks earlier; the cover-page figure was used as the single most current count.
- Newest filing check: the 30 Jun 2026 10-Q (filed 28 Jul 2026) postdates the 31 Dec 2025 10-K (filed 19 Feb 2026), so the 10-Q was used for both shares outstanding and the holdings search; the 10-K was also searched and turned up nothing beyond the same ZENS-Related Securities disclosure.
- Holdings side: CenterPoint's only disclosed equity holdings in other public companies are the three ZENS-Related Securities (AT&T Common, Charter Common, WBD Common) backing its outstanding ZENS notes, per the 30 Jun 2026 10-Q's 'Investment in equity securities' footnote ($404m total: AT&T $211m, Charter $124m, WBD $66m, plus $3m of unidentified 'Other' too small/unspecified to record as a separate holding). Both the 10-Q and the FY2025 10-K were searched for 'equity method', 'unconsolidated affiliate', 'joint venture', 'non-marketable' and 'Enable'/'midstream'/'Energy Transfer': none of those terms appear. CenterPoint's historical Enable Midstream Partners general-partner interest (later converted into Energy Transfer LP units after the 2021 Enable/Energy Transfer merger) does not surface in either filing, indicating that stake has been fully divested; the brief's suggestion to check it is a genuine negative finding, not an omission. Exhibit 21 was not separately pulled because the equity-securities footnote already gave a complete, explicit accounting of every non-subsidiary equity position with actual figures, unlike the ambiguous bare-name-list case described in the brief.
- Register self-gate (computed from this final file, per the brief's own formula): 9 rows, share total 407,844,335, 61.91% of shares_outstanding (658,720,288). This is above the brief's rough 55% ceiling. Investigated and not treated as an error: (1) implied price per share across every 13F row clusters tightly at $43.9-$44.1 (e.g. Capital Research Global Investors $44.04, BlackRock $44.04, State Street $44.05, T. Rowe Associates $44.04 after the thousands correction below), so there is no mixed instrument or mixed basis; (2) the two largest rows were independently cross-checked against contemporaneous Schedule 13G/A filings found via web search: Capital International Investors' 13G/A filed 29 Jul 2026 reports 45,254,971 shares (6.9%) versus this file's 13F-derived 44,148,583 shares (6.7%) for the same entity, and T. Rowe Price Investment Management's 13G/A (signed 8 Jul 2026) reports 66,499,435 shares (10.2%) versus this file's 66,422,281 shares (10.08%); both are within about 1% of the 13F figures, consistent with different measurement dates rather than a double-count. CenterPoint's institutional register is genuinely this concentrated: Capital Group and T. Rowe Price together hold roughly 29% of the company.
- T. Rowe Price Associates, Inc. (CIK 0000080255) and T. Rowe Price Investment Management, Inc. (CIK 0001897612) both file their 13F information tables with the value column in THOUSANDS, not whole dollars, confirmed by implied-price sanity check (raw values of $299,454 and $2,925,238 divide to an implausible fraction of a cent per share; multiplying by 1,000 yields $299,454,000 and $2,925,238,000, both implying ~$44.04/share, consistent with every other Q2 2026 filer). The value_usd fields in this register are the corrected, multiplied-by-1000 figures.
- Vanguard: parent CIK 0000102909 (The Vanguard Group Inc) filed Form 13F-NT (a notice, no holdings) for Q2 2026 (period 2026-06-30, filed 2026-08-13), so per the brief's rule the successor entities ARE the position and were summed rather than substituted with one row. Swept and summed all 8 entities named for Vanguard in this project's own register file data/registers/CNP.json (used for the entity list only): Vanguard Fiduciary Trust Co (CIK 0000933478, 3,674,030 sh), Vanguard Investments Australia, Ltd. (0001550100, 650,915 sh), Vanguard Asset Management, Ltd (0001680208, 1,405,840 sh), Vanguard Personalized Indexing Management, LLC (0001767306, 70,032 sh), Vanguard Global Advisers, LLC (0001811242, 1,411,153 sh), Vanguard National Trust Co (0001984256, 56 sh), Vanguard Capital Management LLC (0002100119, 42,737,918 sh), Vanguard Portfolio Management LLC (0002100121, 33,968,721 sh). Each entity's own Q2 2026 13F-HR information table was read directly for these figures; none were taken from the register snapshot.
- Capital Group: swept all 5 entities named for Capital Group in this project's register file (entity list only, figures refetched from each entity's own Q2 2026 13F-HR): Capital Research Global Investors (CIK 0001422848, 71,382,073 sh), Capital International Investors (0001562230, 44,148,583 sh), Capital World Investors (0001422849, 6,385,136 sh), Capital International, Inc./CA/ (0000895213, 868,185 sh), Capital International Sarl (0001065349, 127,274 sh). This is a family roll-up (not is_aggregate; nothing rolls into it), consistent with the brief's Capital Group guidance.
- The proxy's own 5%-holder table (as of 27 Feb 2026) reports stale figures from older Schedule 13G/13G/A filings for Vanguard (76,442,771 sh, 11.69%, 13G/A filed 13 Feb 2024), Capital Research Global Investors alone (66,250,536 sh, 10.13%, 13G filed 5 Feb 2026), T. Rowe Price Investment Management (58,286,690 sh, 8.91%, undated in the excerpt captured), BlackRock (49,577,998 sh, 7.58%, 13G/A filed 26 Jan 2024), Capital International Investors alone (33,877,794 sh, 5.18%), and State Street (33,091,954 sh, 5.06%, 13G filed 11 Aug 2025). Per the brief's guidance to prefer the fresh Q2 2026 13F over any stale 13G quoted in a proxy, this file uses the fresh 13F sums above instead; all six proxy figures are lower than the corresponding fresh figures, consistent with accumulation over 2025-2026 rather than a data error.
- BlackRock, State Street and FMR each also reported a small derivative position in CenterPoint's 4.250% Notes due 8/1 (CUSIP 15189TBD8) in their Q2 2026 13F filings; these are debt derivatives, not common stock, and were excluded from every share/value figure above per scripts/filing.py's own handling.
- The proxy statement's officers/directors aggregate ('All current executive officers, directors and nominees for director as a group (16 persons)', 1,226,547 shares, reported as 'less than one percent') is included as a single insider row; individual director/officer holdings (the largest being CEO Jason P. Wells at 453,065 shares) are all too small individually to warrant separate rows, so no members are broken out and the aggregate stands at its full reported value with is_aggregate:true and no rows rolling into it.
Looked for, not found
Recorded rather than filled in. Each of these is a place where a number could have been invented and was not.
- The exact price per share used to convert the T. Rowe Price entities' thousands-denominated values is not separately disclosed; the $1,000 multiplier was inferred from the implied-price cross-check against every other Q2 2026 filer's CenterPoint position, not confirmed by a T. Rowe Price statement of methodology.
- The proxy's insider table lists per-person shares as of 27 Feb 2026 for named executives and directors individually, but this file does not break each one out as a separate row since none individually crosses a size threshold worth a dedicated line; a reader wanting the per-director breakdown should consult the DEF 14A directly (source_urls above).
- No sovereign or single strategic corporate holder at any size was found in the register, the proxy's 5%-holder table, or the family sweeps above; this appears to be a genuine negative rather than a gap.
- The $3 million 'Other' component of CenterPoint's $404 million ZENS-Related Securities balance (30 Jun 2026) is not identified by security name in the 10-Q, so it could not be recorded as a holding.
- Whether the Warner Bros. Discovery/Paramount Skydance merger has since closed (expected H2 2026, per the 10-Q) was not checked as of this research date; if it has closed, CenterPoint's WBD stake would have converted to cash and the ZENS-Related Securities basket would now consist only of AT&T Common and Charter Common.